Related Experiment Video
Updated: Jul 16, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
Dipeptidyl peptidase II (DPPII), a review
Marie-Berthe Maes1, Simon Scharpé, Ingrid De Meester
1Laboratory for Medical Biochemistry, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, Belgium.
Proline-specific dipeptidyl peptidases (DPPs) regulate biological processes. Dipeptidyl peptidase II (DPPII) is an intracellular protease with suggested roles in cell differentiation and disease, though its function remains unclear.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Proline-specific N-terminal processing regulates numerous biological processes.
- Dipeptidyl peptidases (DPPs) are a protease family involved in signaling by peptide hormones.
- Dipeptidyl peptidase II (DPPII) is an intracellular protease found in the vesicular system.
Purpose of the Study:
- To review the current literature on Dipeptidyl peptidase II (DPPII).
- To clarify the dispersed data regarding DPPII's functions and roles.
- To provide a state-of-the-art overview of DPPII research.
Main Methods:
- Literature review of existing studies on DPPII.
- Analysis of reported enzyme localization in cells, body fluids, and organs.
- Examination of suggested physiological and pathological roles of DPPII.
Main Results:
- DPPII prefers cleaving N-terminal dipeptides from oligopeptides with Pro or Ala at the penultimate position, optimally at acidic pH.
- DPPII has been suggested to be involved in cell differentiation, protection from cell death, and degradation of collagen fragments, myofibrillar proteins, and neuropeptides.
- Changes in DPPII levels and distribution suggest roles in disease-related processes.
Conclusions:
- The precise physiological role of DPPII is not yet fully elucidated.
- DPPII's localization and suggested functions point to diverse biological roles.
- Further research is needed to consolidate the understanding of DPPII's functions and implications in health and disease.
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Insulin Secretory Vesicles
